Skip to main content
. 2023 Aug 2;11(6):101063. doi: 10.1016/j.gendis.2023.06.032

Table 1.

Non-coding RNAs regulate cisplatin resistance in ovarian cancer.

Type Gene name Main target gene Function Reference
MiRNA miR-29 COL1A1 Cisplatin sensitivity 88
miR-216b PARP1 Cisplatin sensitivity 89
miR-378a-3p MAPK1, GRB2 Cisplatin sensitivity 90
miR-130a XIAP Cisplatin sensitivity 91
miR-146b FBXL10 Cisplatin sensitivity 92
miR-133b, miR-186 MDR1, GST-π Cisplatin sensitivity 93, 94
miR-132 BMI-1 Cisplatin sensitivity 95
miR-302 ATAD2 Cisplatin sensitivity 96
miR-152, miR-185 DNMT1 Cisplatin sensitivity 97
miR-149–3p CDKN1A, TIMP2 Cisplatin resistance 98
LncRNA MCF2L-AS1 IGF2BP1 Cisplatin resistance 100
ACTA2-AS1 Wnt5a Cisplatin resistance 101
CASC10 NUP43 Cisplatin resistance 102
HOXA11-AS Beclin1, LC3-II/I Cisplatin resistance 103
WDFY3-AS2 SDC4 Cisplatin resistance 104
CTSLP8 PKM2, c-Myc Cisplatin resistance 105
LINC01508 YAP Cisplatin resistance 106
PRKAR1B-AS2 PI3K, AKT, mTOR Cisplatin resistance 107
CERNA1 BCL2L10 Cisplatin sensitivity 108
SLC25A21-AS1 KCNK4 Cisplatin sensitivity 109
CircRNA circSnx12 SLC7A11 Cisplatin resistance 112
circPBX3 IGF2BP2, ATP7A Cisplatin resistance 113
circTYMP1 TGF1B Cisplatin resistance 114
circCdr1as SCAI Cisplatin sensitivity 115
circLPAR3 PDK1 Cisplatin resistance 116